SCHEMBL16675555

SCHEMBL16675555

c1ccc2c(c1)c1ccccc1c1[nH]c(-c3ccc(-c4nc5c6ccccc6c6ccccc6c5[nH]4)cc3)nc21

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 6/20 0.62
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
KDM4E B2RXH2 2/20 0.62
ALDH1A1 P00352 2/20 0.62
GLA P06280 2/20 0.62
GAA P10253 2/20 0.62
MAPT P10636 2/20 0.62
NPC1 O15118 2/20 0.62
POLB P06746 2/20 0.62
RAB9A P51151 2/20 0.62
IDO1 P14902 1/20 0.62
RECQL P46063 1/20 0.62
TDO2 P48775 1/20 0.62
ATM Q13315 1/20 0.62
LMNA P02545 1/20 0.60
HPGD P15428 1/20 0.60
MAPK1 P28482 1/20 0.60
HTT P42858 1/20 0.60
NOX1 Q9Y5S8 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30373338 1.00 PTGES (0.62) PTGESMEN1KMT2AKDM4EALDH1A1
SCHEMBL16667971 1.00 PTGES (0.62) PTGESMEN1KMT2AKDM4EALDH1A1
SCHEMBL2951161 0.94 ALDH1A1 (0.60) PTGESMEN1KMT2AKDM4EALDH1A1
SCHEMBL29829906 0.94 ALDH1A1 (0.60) PTGESMEN1KMT2AKDM4EALDH1A1
SCHEMBL13007531 0.91 PTGES (0.54) PTGESMEN1KMT2AKDM4EALDH1A1
SCHEMBL29861634 0.91 PTGES (0.55) PTGESMEN1KMT2AKDM4EALDH1A1
SCHEMBL762462 0.91 PTGES (0.54) PTGESMEN1KMT2AKDM4EALDH1A1
SCHEMBL29065756 0.91 GAA (0.62) PTGESMEN1KMT2AKDM4EALDH1A1
SCHEMBL14023475 0.91 MEN1 (0.57) PTGESMEN1KMT2AKDM4EALDH1A1
SCHEMBL28049482 0.91 PTGES (0.62) PTGESMEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452989-B2 Compounds, sensors, methods, and systems for detecting gamma radiation UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2016-09-27 US disclosed
US-9452989-B2 Compounds, sensors, methods, and systems for detecting gamma radiation UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2016-09-27 US disclosed
US-20150118758-A1 COMPOUNDS, SENSORS, METHODS, AND SYSTEMS FOR DETECTING GAMMA RADIATION UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2015-04-30 US disclosed
US-20150118758-A1 COMPOUNDS, SENSORS, METHODS, AND SYSTEMS FOR DETECTING GAMMA RADIATION UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2015-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150118758-A1 COMPOUNDS, SENSORS, METHODS, AND SYSTEMS FOR DETECTING GAMMA RADIATION RAD50, MRE11, IRF3 PTGES 2304/4885MEN1 365/4885KMT2A 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.